Your browser doesn't support javascript.
loading
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.
Sakthikumar, Sharadha; Facista, Salvatore; Whitley, Derick; Byron, Sara A; Ahmed, Zeeshan; Warrier, Manisha; Zhu, Zhanyang; Chon, Esther; Banovich, Kathryn; Haworth, David; Hendricks, William P D; Wang, Guannan.
Afiliación
  • Sakthikumar S; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Facista S; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Whitley D; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Byron SA; Translational Genomics Research Institute, Phoenix, Arizona, USA.
  • Ahmed Z; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Warrier M; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Zhu Z; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Chon E; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Banovich K; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Haworth D; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Hendricks WPD; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
  • Wang G; Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
Vet Comp Oncol ; 21(3): 482-491, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37248814
The accrual of cancer mutation data and related functional and clinical associations have revolutionised human oncology, enabling the advancement of precision medicine and biomarker-guided clinical management. The catalogue of cancer mutations is also growing in canine cancers. However, without direct high-powered functional data in dogs, it remains challenging to interpret and utilise them in research and clinical settings. It is well-recognised that canine and human cancers share genetic, molecular and phenotypic similarities. Therefore, leveraging the massive wealth of human mutation data may help advance canine oncology. Here, we present a structured analysis of sequence conservation and conversion of human mutations to the canine genome through a 'caninisation' process. We applied this analysis to COSMIC, the Catalogue of Somatic Mutations in Cancer, the most prominent human cancer mutation database. For the project's initial phase, we focused on the subset of the COSMIC data corresponding to Cancer Gene Census (CGC) genes. A total of 670 canine orthologs were found for 721 CGC genes. In these genes, 365 K unique mutations across 160 tumour types were converted successfully to canine coordinates. We identified shared putative cancer-driving mutations, including pathogenic and hotspot mutations and mutations bearing similar biomarker associations with diagnostic, prognostic and therapeutic utility. Thus, this structured caninisation of human cancer mutations facilitates the interpretation and annotation of canine mutations and helps bridge the knowledge gap to enable canine precision medicine.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de los Perros / Neoplasias Límite: Animals / Humans Idioma: En Revista: Vet Comp Oncol Asunto de la revista: MEDICINA VETERINARIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de los Perros / Neoplasias Límite: Animals / Humans Idioma: En Revista: Vet Comp Oncol Asunto de la revista: MEDICINA VETERINARIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido